FDA
-
-
-
-
-
-
-
Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula
-
-
-
-
-
-
-
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
-
-
-
-
-
-
-
Abbott receives FDA clearance for AI-powered coronary imaging platform
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Lowered to $132 at Oppenheimer
-
-
-
-
-
-
-
Abbott receives FDA clearance for delivery system for premature infants
-
-
-
-
-
-
-
Abbott (ABT) Receives FDA Approval for Tendyne
-
-
-
-
-
-
-
Abbott (ABT) initiates new trail for Coronary IVL System
-
331,677 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

